Related references
Note: Only part of the references are listed.Androgens, the kidney, and COVID-19: an opportunity for translational research
Licy L. Yanes Cardozo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2021)
Use of sodium-glucose co-transporter-2 inhibitors in patients with and without type 2 diabetes: implications for incident and prevalent heart failure
Javed Butler et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
SGLT2 Inhibitor Induced Sympathoinhibition A Novel Mechanism for Cardiorenal Protection
Lakshini Y. Herat et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2020)
Effects of empagliflozin on metabolic parameters in polycystic ovary syndrome: A randomized controlled study
Zeeshan Javed et al.
CLINICAL ENDOCRINOLOGY (2019)
Diuretic Effects of Sodium Glucose Cotransporter 2 Inhibitors and Their Influence on the Renin-Angiotensin System
Tuba M. Ansary et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Obesity, kidney dysfunction and hypertension: mechanistic links
John E. Hall et al.
NATURE REVIEWS NEPHROLOGY (2019)
Sodium-Glucose Cotransporter 2 Inhibition and Diabetic Kidney Disease
Radica Z. Alicic et al.
DIABETES (2019)
Effect of GLP-1 Receptor Agonists in the Cardiometabolic Complications in a Rat Model of Postmenopausal PCOS
Edgar D. Torres Fernandez et al.
ENDOCRINOLOGY (2019)
Serum testosterone acts as a prognostic indicator in polycystic ovary syndrome-associated kidney injury
Yali Song et al.
PHYSIOLOGICAL REPORTS (2019)
Canagliflozin Prevents Intrarenal Angiotensinogen Augmentation and Mitigates Kidney Injury and Hypertension in Mouse Model of Type 2 Diabetes Mellitus
T. Cooper Woods et al.
AMERICAN JOURNAL OF NEPHROLOGY (2019)
MicroRNA-21 ablation exacerbates aldosterone-mediated cardiac injury, remodeling, and dysfunction
Maryam Syed et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2018)
Long-Lasting Androgen-Induced Cardiometabolic Effects in Polycystic Ovary Syndrome
Edgar D. Torres Fernandez et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2018)
Delayed Diagnosis and a Lack of Information Associated With Dissatisfaction in Women With Polycystic Ovary Syndrome
Melanie Gibson-Helm et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Putative tissue location and function of the SLC5 family member SGLT3
Matus Sotak et al.
EXPERIMENTAL PHYSIOLOGY (2017)
Cardiometabolic Features of Polycystic Ovary Syndrome: Role of Androgens
Licy L. Yanes Cardozo et al.
PHYSIOLOGY (2017)
The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats
Sebastian Steven et al.
REDOX BIOLOGY (2017)
SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice
Liang Xu et al.
EBIOMEDICINE (2017)
Inhibition of Renal Sodium-Glucose Cotransport With Empagliflozin Lowers Fasting Plasma Glucose and Improves β-Cell Function in Subjects With Impaired Fasting Glucose
Muhammad Abdul-Ghani et al.
DIABETES (2017)
The Sodium Glucose Cotransporter 2 Inhibitor Ipragliflozin Promotes Preferential Loss of Fat Mass in Non-obese Diabetic Goto-Kakizaki Rats
Toshiyuki Takasu et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2017)
Sodium glucose cotransporter 2 inhibition in the diabetic kidney: an update
Aleksandra Novikov et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2016)
Sodium glucose cotransporter SGLT1 as a therapeutic target in diabetes mellitus
Panai Song et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2016)
The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis
Gurkan Bozdag et al.
HUMAN REPRODUCTION (2016)
Polycystic Ovary Syndrome
Christopher R. McCartney et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Effect of Sodium-Glucose Co-Transporter 2 Inhibitor, Dapagliflozin, on Renal Renin-Angiotensin System in an Animal Model of Type 2 Diabetes
Seok Joon Shin et al.
PLOS ONE (2016)
Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice
Linda A. Gallo et al.
SCIENTIFIC REPORTS (2016)
Sodium-Glucose Cotransporter Inhibitors: Effects on Renal and Intestinal Glucose Transport: From Bench to Bedside
Sunder Mudaliar et al.
DIABETES CARE (2015)
Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome
Daniel A. Dumesic et al.
ENDOCRINE REVIEWS (2015)
Effect of insulin on AKR1C3 expression in female adipose tissue: in-vivo and in-vitro study of adipose androgen generation in polycystic ovary syndrome
Michael O'Reilly et al.
LANCET (2015)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Sodium-Glucose Linked Transporter-2 Inhibitors in Chronic Kidney Disease
L. Zanoli et al.
TheScientificWorldJOURNAL (2015)
Sodium-Glucose Linked Transporter-2 Inhibitors in Chronic Kidney Disease
L. Zanoli et al.
Scientific World Journal (2015)
Renoprotective effects of combined SGLT2 and ACE inhibitor therapy in diabetic Dahl S rats
Naoki Kojima et al.
PHYSIOLOGICAL REPORTS (2015)
The SGLT2 inhibitor empagliflozin ameliorates early features of diabetic nephropathy in BTBR ob/ob type 2 diabetic mice with and without hypertension
Florian Gembardt et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2014)
Stain-Free total protein staining is a superior loading control to β-actin for Western blots
Jennifer E. Gilda et al.
ANALYTICAL BIOCHEMISTRY (2013)
Glucose transport families SLC5 and SLC50
Ernest M. Wright
MOLECULAR ASPECTS OF MEDICINE (2013)
Expression of Na+-D-glucose cotransporter SGLT2 in rodents is kidney-specific and exhibits sex and species differences
Ivan Sabolic et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2012)
The Vasodilatory Effect of Testosterone on Renal Afferent Arterioles
Yan Lu et al.
GENDER MEDICINE (2012)
Murine Recombinant Angiotensin-Converting Enzyme 2 Effect on Angiotensin II-Dependent Hypertension and Distinctive Angiotensin-Converting Enzyme 2 Inhibitor Characteristics on Rodent and Human Angiotensin-Converting Enzyme 2
Minghao Ye et al.
HYPERTENSION (2012)
Species-specific inhibitor sensitivity of angiotensin-converting enzyme 2 (ACE2) and its implication for ACE2 activity assays
Kim Brint Pedersen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2011)
Cardiovascular-Renal and Metabolic Characterization of a Rat Model of Polycystic Ovary Syndrome
Licy L. Yanes et al.
GENDER MEDICINE (2011)
Intratubular Renin-Angiotensin System in Hypertension
L. Gabriel Navar et al.
HYPERTENSION (2011)
Renin and cardiovascular disease: Worn-out path, or new direction?
Gaurav Alreja et al.
WORLD JOURNAL OF CARDIOLOGY (2011)
The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria
Wendy A. March et al.
HUMAN REPRODUCTION (2010)
Hyperreninemia Characterizing Women with Polycystic Ovary Syndrome Improves after Metformin Therapy
Evanthia Diamanti-Kandarakis et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2009)
Decreased androgen levels and improved menstrual pattern after angiotensin II receptor antagonist telmisartan treatment in four hypertensive patients with polycystic ovary syndrome: Case series
Mojca Jensterle et al.
CROATIAN MEDICAL JOURNAL (2007)
Rat renal glucose transporter SGLT1 exhibits zonal distribution and androgen-dependent gender differences
I Sabolic et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2006)
Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome
JC Lo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Angiotensin II-dependent increased expression of Na+-glucose cotransporter in hypertension
R Bautista et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2004)
Androgen generation in adipose tissue in women with simple obesity -: a site-specific role for 17β-hydroxysteroid dehydrogenase type 5
M Quinkler et al.
JOURNAL OF ENDOCRINOLOGY (2004)
Angiotensin-converting enzyme-2 (ACE2): Comparative modeling of the active site, specificity requirements, and chloride dependence
JL Guy et al.
BIOCHEMISTRY (2003)
Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase
C Vickers et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Prevalence of diabetes mellitus, hypertension and cardiac complaints in a follow-up study of a Dutch PCOS population
MW Elting et al.
HUMAN REPRODUCTION (2001)
Standardization of a fluorimetric assay for the determination of tissue angiotensin-converting enzyme activity in rats
EM Oliveira et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2000)
Share Paper
